Next Article in Journal
The Current Findings on the Impact of Prenatal BPA Exposure on Metabolic Parameters: In Vivo and Epidemiological Evidence
Next Article in Special Issue
Comparison of the Concordance of Cardiometabolic Diseases and Physical and Laboratory Examination Findings between Monozygotic and Dizygotic Korean Adult Twins: A Cross-Sectional Study Using KoGES HTS Data
Previous Article in Journal
Different Dose of Sucrose Consumption Divergently Influences Gut Microbiota and PPAR-γ/MAPK/NF-κB Pathway in DSS-Induced Colitis Mice
Previous Article in Special Issue
Impact of Lipid Genetic Risk Score and Saturated Fatty Acid Intake on Central Obesity in an Asian Indian Population
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 14
Issue 13
10.3390/nu14132763
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Interactions between Vitamin D Genetic Risk and Dietary Factors on Metabolic Disease-Related Outcomes in Ghanaian Adults

by
Buthaina E. Alathari
1,2,
David A. Nyakotey
3,4,
Abdul-Malik Bawah
3,
Julie A. Lovegrove
1,5,
Reginald A. Annan
3,
Basma Ellahi
6 and
Karani S. Vimaleswaran
1,5,7,*
1
Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, Harry Nursten Building, Pepper Lane, University of Reading, Reading RG6 6DZ, UK
2
Department of Food Science and Nutrition, Faculty of Health Sciences, The Public Authority for Applied Education and Training, P.O. Box 14281, AlFaiha 72853, Kuwait
3
Department of Biochemistry and Biotechnology, College of Science, Kwame Nkrumah University of Science and Technology, Accra Road, Kumasi GH233, Ghana
4
Liggins Institute, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand
5
Institute of Cardiovascular and Metabolic Research, Harry Nursten Building, Pepper Lane, University of Reading, Reading RG6 6DZ, UK
6
Faculty of Health and Social Care, University of Chester, Riverside Campus, Chester CH1 4BJ, UK
7
Institute for Food, Nutrition and Health, University of Reading, Reading RG6 6AH, UK
*
Author to whom correspondence should be addressed.
Nutrients 2022, 14(13), 2763; https://doi.org/10.3390/nu14132763
Submission received: 21 May 2022 / Revised: 22 June 2022 / Accepted: 27 June 2022 / Published: 4 July 2022
(This article belongs to the Special Issue Gene-Lifestyle Interactions on Cardiometabolic Diseases)
Browse Figures
Versions Notes

Abstract

:
The Ghanaian population is experiencing an upsurge in obesity and type 2 diabetes (T2D) due to rapid urbanization. Besides dietary factors, vitamin D-related genetic determinants have also been shown to contribute to the development of obesity and T2D. Hence, we aimed to examine the interactions between dietary factors and vitamin D-related genetic variants on obesity and T2D related outcomes in a Ghanaian population. Three hundred and two healthy Ghanaian adults (25–60 years old) from Oforikrom, Municipality in Kumasi, Ghana were randomly recruited and had genetic tests, dietary consumption analysis, and anthropometric and biochemical measurements of glucose, HbA1c, insulin, cholesterol, and triglycerides taken. A significant interaction was identified between vitamin D-GRS and fiber intake (g/day) on BMI (pinteraction = 0.020) where those who were consuming low fiber (≤16.19 g/d) and carrying more than two risk alleles for vitamin D deficiency (p = 0.01) had a significantly higher BMI. In addition, an interaction between vitamin D-GRS and fat intake (g/day) on HbA1c (total fat, pinteraction = 0.029) was found, where participants who had a lower total fat intake (≤36.5 g/d), despite carrying more than two risk alleles, had significantly lower HbA1c (p = 0.049). In summary, our study has identified novel gene–diet interactions of vitamin D-GRS with dietary fiber and fat intakes on metabolic traits in Ghanaian adults.

1. Introduction

There is an observed increase in the prevalence of obesity and Type 2 diabetes (T2D) in Sub-Saharan African (SSA) countries, and their related chronic diseases which are becoming a rising cause of morbidity and mortality [1,2,3]. Ghana is a West African country with a public health concern of an increase in obesity and overweightness, which is mainly attributed to rapid urbanization along with increased industrialization, use of motorized transport, increased income, a Westernized diet, and reduced physical activity [4,5,6]. The prevalence of the combined percentage of overweightness and obesity in Ghana was reported to be around 43% in a systemic review meta-analysis in 48,966 adults (mean age range: 23–56.2 years old) from ten regions in Ghana [7]. Likewise, in 2018, the prevalence of T2D in Ghanaian adults has been estimated to be in the range of 6.2–13.9% [8] with a substantial proportion of undiagnosed cases that typically are identified with the onset of diabetic complications [9,10]. Various factors predispose individuals to develop obesity and T2D including older age, diet, and inactivity. Additionally, genome-wide association studies (GWAS) in diverse populations have discovered more than 1100 loci to be associated with obesity traits and nearly 600 loci to be associated with T2D risk, suggesting the role of genetic factors in metabolic diseases [11,12].
Vitamin D deficiency status has been demonstrated to be influenced by several genetic factors, including genes involved with its synthesis and metabolism [13,14]. The 7-dehydrocholesterol reductase gene (DHCR7) encodes the enzyme that converts 7-dehydrocholesterol (7DHC) to cholesterol, [15,16,17], and the 25-hydroxylase gene (CYP2R1) encodes the enzyme that converts vitamin D to the circulating form 25(OH)D [16,17,18]. Vitamin D metabolism genes include the 24 hydroxylase gene (CYP24A1), which encodes the enzyme that catabolizes the biologically active form of vitamin D (1,25-dihydroxyvitamin D) to the inactive and water-soluble calcitroic acid, the excretory product of vitamin D metabolism, thus, controlling the amount of active vitamin D in the blood [16,17,19], the vitamin D binding protein (DBP)/group-specific component gene (GC), which binds to 25-hydroxyvitamin D and its plasma metabolites to transport them to target tissues [16,17,20], and the vitamin D receptor gene (VDR), which encodes the nuclear vitamin D receptor and heterodimerizes with the retinoid X receptor (RXR) to enable the biological activities of 1,25-dihydroxyvitamin D [21,22]. Finally, the calcium sensing receptor gene (CASR), which is important in regulating calcium homeostasis and synthesis of the parathyroid hormone (PTH), has been shown to stimulate the synthesis of 1,25-dihydroxyvitamin D [23,24]. Numerous studies have identified genetic variants associated with vitamin D status and those genetic markers have been validated as genetic instruments for low vitamin D concentrations [13,16,21].
Several epidemiological studies investigating the link between vitamin D status and metabolic traits have reported inconsistent findings where some studies found an association between vitamin D deficiency and metabolic outcomes [25,26,27] while other studies failed to find any connection [25,26,27,28]. Using genetic variants to examine the relationship between vitamin D status and metabolic disease outcomes has been shown to be an effective method to overcome confounding [29]. Therefore, the aims of this study were to use a nutrigenetic approach to determine whether a genetic risk score (GRS) of eight single nucleotide polymorphisms (SNPs) from six selected candidate genes related to vitamin D deficiency was associated with metabolic disease-related traits and whether these associations were modified by dietary intake in 302 randomly chosen healthy adults from Oforikrom, Ghana.

2. Methodology

2.1. Study Population

Study population was taken from the Genetics of Obesity and Nutrition in Ghana (GONG) study, which is a cross-sectional study in healthy Ghanaian adults aged 25–60 years. The study which took place in Oforikrom Municipality in Kumasi, Ashanti region, Ghana. The GONG study is a part of the Gene–Nutrient Interactions (GeNuIne). Collaboration, the main objective of which is to explore gene–nutrient interactions on metabolic disease outcomes in different ethnicities using population-based studies from various countries [30,31,32,33]. The Oforikrom Municipal Assembly is one of the 43 districts in the Ashanti region in Ghana. Oforikrom was a part of the Kumasi Metropolitan Assembly until 2018 when it was elevated to a municipal assembly district. In the Oforikrom Municipal Assembly there are seventeen recognized communities with an estimated total population of 360,254. Five communities (Oforikrom, Ayeduase, Ayigya, Kotei, and Bomso) were randomly selected from the list of communities in the Oforikrom Municipal Assembly. In each community, a central point was located (automobile station, marketplace, or a landmark). An assigned field investigator chose to enter the first house that is facing either East, West, North or South of that central point. After selecting the house, the investigator requested to randomly recruit one person from the household. If no one agreed to participate in the household, the investigator moved on to the next household. Subsequently, the fieldworker entered the next house, and the selection process was repeated. All participants freely agreed to participate using a written informed consent.
A total of three hundred and two healthy free-living and adult volunteers were included in this study. Participants had no prior diagnosis of disease or physical complaints; all participants were screened and recruited for the study by trained investigators (Figure 1). A pre-questionnaire was developed and used where participants were asked if they had been diagnosed with cancer, diabetes, high cholesterol, high blood pressure, inflammatory, respiratory, gastrointestinal, thyroid, renal, liver or heart diseases, and about medication use and recent surgeries, to eliminate any unhealthy volunteers. The inclusion criteria were: (a) age from 25 to 60 years old; (b) healthy adults; and (c) both parents to be Asante ethnicity. The exclusion criteria were: (a) age less than 25 years or above 60 years; (b) pregnant women; (c) current diagnosis or having a history of communicable disease or any non-communicable diseases such as, cardiovascular diseases, T2D, and hypertension; and (d) use of medication for controlling diabetes, and hypertension, or lipid-lowering drugs.
Ethical approval was obtained from the Council for Scientific and Industrial Research (CSIR) Institutional Review Board (IRB) (Ref: RPN 003/CSIR-IRB/2018). Furthermore, this study was approved by the Metro Director of Health Services, Kumasi (KMHD/MPHs/13). An informed consent form was signed by each participant prior to their participation in the study.

2.2. Data Collection

Questionnaires were used to gather information about the participants’ demographic characteristics, dietary intakes, sleep, sunshine exposure patterns, and medical history, and demographic characteristics. Proper training was provided to the field investigators prior to the start of data collection. The instruments used for the survey were pre-tested to make sure that investigators had complete understanding of the questionnaires. The study was conducted from July to September 2018.
Anthropometric data [weight, height, hip circumference (HC), waist circumference (WC), visceral fat, and body fat percentage (BFP)] were measured with participants wearing light clothing. Height was measured to the nearest 0.1 cm, with a stadiometer (Seca 213 mobile stadiometer, Hamburg, Germany) with participants standing upright without shoes. Weight was measured to the nearest 0.1 kg, using an OMRON Body Composition Analyzer which also provided the values for the visceral fat, BFP, and body mass index (BMI). Non-extensible measuring tape was used to measure HC and WC. The HC was measured at the level of the greater trochanter to the nearest 0.1 cm whereas the WC was measured just above the naval to the nearest 0.1 cm. Waist-to-hip ratio (WHR) was calculated by dividing WC by HC.

2.3. Biochemical Measurements

Blood samples were collected via venipuncture after an 8–12 h fast from each participant by a trained phlebotomist. Fasting plasma glucose, glycated haemoglobin (HbA1c), fasting insulin, and lipid profile were analyzed. Fluoride tubes and ethylene–diaminetetra acetic acid (EDTA) tubes were used to collect blood samples which were stored in ice packs for temporary storage and transported to the Clinical Analyses Laboratory, KNUST for analysis. Blood glucose was analyzed using a semi-automated spectrophotometer (Biolabo Diagnostic Kenza Biochemistry Try, France). Fasting serum insulin was analyzed using an enzyme-linked immunosorbent assay (ELISA) kit. Ion-exchange chromatography method was used to determine total glycated hemoglobin. Total cholesterol, HDL-c, and serum triglycerides concentrations were determined by using a semi-automated spectrophotometer (Humalyzer Junior, Human GmBH Germany). The Friedewald formula was used to compute concentration of LDL-c in all the samples. All test kits were from Medsource Ozone Biomedicals Pvt. Ltd. Haryana, India

3. Assessment of Dietary Intake

A repeated three-day 24-h dietary recall (one weekend day and two weekdays) was used to extract the participants’ dietary intake data. The participants were asked to recall time of all meals taken and all the content of the consumed meals. Common household measures were used to help participants accurately estimate the actual amounts of foods and drinks consumed. An African specific dietary software (Nutrient Analysis Template; Food Science and Nutrition Department, University of Ghana, Accra, Ghana, 2010) was then used to analyse the nutritional composition of the participants’ diet.

SNP Selection, GRS Construction and Genotyping

The following 8 SNPs were selected based on their known association with vitamin D concentrations: VDR SNPs rs2228570 and rs7975232 [24,34]; DHCR7 SNP rs12785878 [24,35,36,37,38]; CYP2R1 SNPs rs12794714 and rs10741657 [21,24,37,39,40]; CYP24A1 SNP rs6013897 [24,36,40]; DBP/GC SNP rs2282679 [35,39]; CASR SNP rs1801725 [24,41]. Selected gene variants were tested using a goodness-of-fit Chi-squared test and all were in Hardy–Weinberg equilibrium (HWE) (p > 0.05) (Supplementary Table S1).
The collected blood samples for the DNA analyses were transported in dry ice to the United Kingdom (UK). Subsequently, genomic DNA extraction took place from a 5 mL whole blood sample from each participant, and genotyping was performed using the competitive allele-specific PCR-KASP assay at the LGC Genomics (http://www.lgcgroup.com/services/genotyping, accessed on 26 June 2022).
Vitamin D-related GRS was constructed by the addition of the sums of the risk allele across each of the eight SNPs. Given that there are no studies pertaining to vitamin D risk allele data in the West African population, the risk alleles for the present study were determined based on studies that were carried out in Caucasian populations [34,42,43,44,45,46,47,48,49,50,51,52]. Each single SNP was assigned a value of 0, 1, or 2 and this value designates the number of risk alleles. Subsequently, these values were calculated by the addition of the total risk alleles across each SNP and the score ranged from 0 to 6 risk alleles. Risk allele scores were then divided by the median, which was 2 risk alleles, and categorized into a “low genetic risk group” and a “high genetic risk group.” By use of the median of vitamin D-related GRS, low risk and high risk were categorized as individuals carrying less than 2 risk alleles (n = 68) and those carrying 2 or more risk alleles (n = 211), respectively. The risk alleles were not weighted, since no previously reported effect sizes were available for these SNPs for Ghanaians, and weighting of risk alleles has shown to have only limited effects [53]. Sample size calculations could not be performed because there were no previously reported effect sizes available for these SNPs for Ghanaians.

4. Statistical Analysis

Analyses of data were performed using Statistical Package for the Social Sciences (SPSS) software (version 27; SPSS Inc., Chicago, IL, USA). Descriptive characteristcs of study population were given as means and standard deviations (SD) for continuous variables, and between group comparisons were tested using an independent samples t-test. The Shapiro–Wilk test of normality was performed on continuous variables to test if the variables were in normal distribution. All variables were non-normally distributed; therefore, natural log transformation values were used in association and interaction analyses for all variables. General linear models (GLM) were used to analyze the association between vitamin D-related GRS and biochemical and clinical metabolic outcomes (BMI, WC, WHR, BFP, glucose, HbA1c, fasting insulin). The vitamin D-GRS and dietary intake interactions were also analyzed using GLM by incorporating the interaction terms in these models. Models were adjusted for age, gender, and BMI (when BMI was not an outcome), and total energy intake (only in the nutrient–GRS interaction analysis). The dietary factors investigated in our study included total dietary intake of carbohydrate, protein, fat, and fiber. If the interaction of the GRS with total fat intake was significant, further analyses were performed to assess the influence of saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), and polyunsaturated fatty acids (PUFA). All vitamin D-GRS and dietary interactions reaching a nominal level of significance were further investigated using a binary and tertile stratification of dietary factors. The two-tailed value of p < 0.05 was considered statistically significant.

5. Results

5.1. Characteristics of Study Participants

GONG study participants were stratified by gender, and their baseline characteristics of clinical, anthropometric, biochemical, and dietary measurements were compared and summarized in Table 1. The mean BMI and total energy intake of all participants were 26.6 ± 5.0 kg/m2 and 1645 ± 688 kcal, respectively. Several significant differences in clinical, anthropometric, and dietary measurements were identified between men and women. Women had a significantly higher age, BMI, WC, and BFP than men (p < 0.003). Conversely, men had a significantly higher total energy intake and higher dietary intake of all measured nutrients: protein, carbohydrates, fat, SFA, MUFA, PUFA and fiber (p < 0.006). However, there were no significant differences in biochemical measurements (glucose, HbA1c and fasting insulin) between women and men.

5.2. Genetic Associations between Vitamin D-GRS and Metabolic Traits

No statistically significant associations were found between vitamin D-GRS and anthropometric and biochemical measurements (p > 0.12 for all comparisons) (Supplementary Table S2).

5.3. Interactions between Dietary Factors and Vitamin D-GRS on Metabolic Traits

There was a statistically significant interaction between vitamin D-GRS and fiber intake (g/day) on BMI (pinteraction = 0.020). Participants who consumed low fiber (≤16.2 g/d) and carried more than two risk alleles (mean ± SE: 1.45 ± 0.009, p = 0.010) had a significantly higher BMI than participants with less than two vitamin D risk alleles (mean ± SE: 1.40 ± 0.015, p = 0.010) (Figure 2A).
There was also a significant interaction between vitamin D-GRS and fat intake (g/day) on HbA1c (pinteraction = 0.029), where participants who had a lower consumption of dietary fat (≤36.5 g/d) and carried more than two risk alleles (mean ± SE: 0.72 ± 0.005, p = 0.049) had a significantly lower HbA1c than participants with less than two risk alleles (mean ± SE: 0.74 ± 0.010, p = 0.049) (Figure 2B). Total fat was stratified into SFA, MUFA, and PUFA and we found that SFA showed a significant interaction (pinteraction = 0.044) with vitamin D-GRS on HbA1c (Table 2). However, after dividing participants based on SFA intake (low SFA, medium SFA, and high SFA), no significant differences were detected between participants with high or low vitamin D deficiency genetic risk in any of the fat intake groups.

6. Discussion

To the best of our knowledge, our study is the first to use a nutrigenetic approach to examine the interaction between vitamin D genetic variants and dietary factors on metabolic outcomes in healthy West African adults from Ghana. This study demonstrated the association of vitamin D-GRS on BMI, a diagnostic marker of obesity [54,55], through the interaction with dietary fiber intake. Additionally, this study provided evidence for an interaction between vitamin D-GRS and fat intake on HbA1c levels, an indicator of glycemic control [56,57]. Both these findings are in agreement with general dietary recommendations addressing dietary fiber and total dietary fat consumption [58] to decrease the risk of obesity and T2D [59,60,61,62,63]. Our results carry public health implications where individuals with genetic risk of vitamin D deficiency might benefit from adhering to general dietary recommendations to prevent obesity and T2D.
According to the Institute of Medicine (IOM), the dietary guidelines for total daily fiber intake is 14 g/1000 kcal/day and, for total daily fat intake, the recommendation is between 20–35% of total energy intake [58]. In our cohort, the average total energy intake was 1645 kcal/d; hence the recommended average fiber intake should be 23 g/day, and the total recommended fat intake should be between 36.5–64.0 g/day. The findings from our study confirms the importance of adhering to the dietary fiber and fat intake guidelines and emphasizes their importance to individuals with a higher genetic predisposition to vitamin D deficiency to prevent obesity. Our study has demonstrated a significant impact of vitamin D-GRS on BMI which was detected under the influence of a low-fiber diet (≤16.2 g/day); hence increasing the dietary fiber consumption will benefit those individuals who are genetically susceptible. Likewise, reducing the consumption of dietary fat intake (<20 g/day) might be beneficial in improving the glycemic control in genetically susceptible individuals.
The results of our study emphasize the importance of a high fiber diet for individuals who have genetic risk of vitamin D deficiency. The role of dietary fiber in relation to the vitamin D-GRS and BMI is not clear; however, both fiber and vitamin D are involved in the health and regulation of the gut microbiome [64]. Dietary fiber is known to have helpful effects on weight management due to their bulking effect and fermentation by the gut microbiota [65,66]. Prebiotics specifically, when consumed, induce changes in intestinal microbiota diversity and increase the release of short-chain fatty acids (SCFAs), such as butyrate, which has the capacity to regulate anti-inflammation processes [67,68]. Obesity is known to be associated with chronic inflammatory markers, most notably the overexpression of pro-inflammatory cytokines produced in adipose tissues [69]. Furthermore, obesity is associated with altered gut microbiota composition and/or activity in humans [70]. As for vitamin D, studies have demonstrated that vitamin D and its receptor, VDR, can regulate and influence gut microbiota [71,72]. Vitamin D has immune-modulatory properties such as inhibiting inflammation and infections and hence might be important in modifying gut microbiota [64]. As both fiber and vitamin D have anti-inflammatory properties, and both are potential modifiers of the gut microbiome, therefore, our gene–fiber intake interaction on BMI could be possibly a result of the influence of microbiome modulation brought about by reduced dietary fiber intake in participants with an increased genetic susceptibility to vitamin D deficiency. Furthermore, some studies have examined the impact of dietary fiber and genetic markers on obesity outcomes. One study in Asian Indian adults (n = 1618) reported that fiber intake and fat mass obesity gene (FTO) SNPs had a significant influence on BMI and WC (pinteraction = 0.0008), where participants with high fiber intake (44 g/day) had a lower BMI (p = 0.07) and lower WC (p = 0.02) [73]. Another study reported a significant interaction between metabolic-related GRS and fiber intake on BFP, where participants with a higher fiber intake (>19 g/day) had lower BFP [74].
A recent longitudinal observantional study (n = 2500) reported that dietary fiber consumption in Ghanaians (24.9 ± 9.7 g/day) was higher than in Jamaicans, Seychellois, South Africans and Africans from the United States, which could be attributed to the high consumption of cassava in Ghana [75]. Nevertheless, only 43% of the study participants [75] met the recommended dietary guidelines for fiber intake (14 g/1000 kcal/day) established by the Institute of medicine (IOM) [58], and fiber intake continue to decline with rapid urbanization in Ghana [76]. It is established that higher total fiber intake is associated with lower inflammation, obesity, and BMI [58,77]. However, studies focusing on the relationship between fiber intake and obesity in the African population are limited. A recent cross-sectional study in 406 Ghanaian men (20–29 years old) demonstrated a significant inverse relationship between fiber intake and abdominal obesity [78]. Furthermore, a randomized trial in 107 African American women investigating fiber intake after 6- and 18-month dietary weight loss interventions found that the consumption of fiber at the 6-month follow-up was significantly and negatively associated with BMI, and a stronger negative association was found at the 18-month follow-up BMI [79]. It is important to emphasize the importance of increasing fiber intake for individuals at risk of vitamin D deficiency to meet the recommended dietary guidelines to help tackle the current rise in obesity in Ghana.
Nutritional transition from traditional diet to a Westernized diet plays a role in the increasing dietary fat consumption in SSA countries, and Ghana is no exception [76,80]. The effects of the changing diet from a low-fat rural diet to a high fat urban diet have already translated in to increased obesity and T2D in the Ghanaian population [3,81]. A recent nutrigenetics study in healthy Ghanaian adults (n = 302) [74] found a significant interaction between metabolic-related GRS and high total fat intake (>47 g/day) and SFA (>14 g/day) on increased WC, suggesting the existence of an interplay between fat intake and genetic susceptibility on obesity outcomes and supporting the general dietary recommendations to reduce total fat intake and SFA to prevent obesity. Our study showed that a lower fat intake was associated with a better glycemic control for people with an increased genetic risk of vitamin D deficiency. Links between total fat intake and glycemic control have been reported in previous studies on diabetic participants where one crossover clinical trial in diabetic adults (n = 7) from Israel reported that higher dietary fat intake increased glucose concentrations [82]. Additionally, a cross-sectional study in 150 adult participants from New Zealand found that increased SFA was associated with a 6% (95% CI 2–10%; p = 0.004) increase in HbA1c and concluded that reducing SFA maybe helpful in improving glycemic control [83]. Total fat intake seems to have an effect on HbA1c levels; this could be caused by reduced insulin sensitivity, or it could be because higher fat intake is causing an increased hepatic glucose production, which can cause an increase in the peak time and amount of the glucose response [84,85]. Evidence that dietary fat intake can affect glycemic control in vitamin-D-susceptible individuals has important implications for developing strategies to prevent T2D in this subgroup.
Our study has several strengths, of which being the first nutrigenetic study to examine the interaction between vitamin D-related genetic variants of and metabolic traits in healthy West Africans from Ghana is the main strength. In addition, we used the GRS approach which increased the statistical power of our analysis, and reduced the negative impact of multiple testing [21,86]. Furthermore, anthropometric and biochemical measurements were determined using validated techniques by skilled staff. Population stratification was also reduced as the participants were strictly Asante Ghanaians (both parents). Limitations include the small sample size; however, we were still able to identify significant gene–diet interactions, indicating that the study is sufficiently powered to detect significant interactions. We used a repeated 24-h dietary recall method to assess nutrient intake, which could be biased or have some recall errors. The study design is cross-sectional, which is inherently prone to residual confounding [87,88]. Finally, the study population were of a specific ethnic group in Ghana (Asante) which may not represent other ethnic groups in Ghana. Hence, more studies are required to confirm our findings to establish the clinical significance and possible applications as part of metabolic disease prevention.

7. Conclusions

In conclusion, the current study has identified novel gene–diet interactions in the West African Ghanaian population. Our study has shown that low fiber intake was associated with higher obesity and low fat intake was associated with greater glycemic control in vitamin D genetically susceptible individuals. Given that both obesity and T2D are on the rise in Ghana [7,9], our study highlights the importance of implementing strategies to follow IOM dietary guidelines to increase dietary fiber intake to 14 g/1000 kcal/day and to decrease total fat intake to 20% of total energy for genetically susceptible individuals. These gene–diet interaction findings need to be replicated in a larger cohort before any dietary recommendations can be implemented for genetically susceptible individuals.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/nu14132763/s1, Table S1: Genotypic and allelic frequencies of the single nucleotide polymorphisms that were used to create the genetic risk score. Reference [89] was cited in Table S1. Table S2: Genetic associations of vitamin D-GRS with clinical and biochemical measurements.

Author Contributions

Conceptualization, K.S.V. and B.E.; methodology, K.S.V. and B.E.A.; software, B.E.A., D.A.N. and A.-M.B.; validation, D.A.N. and A.-M.B.; formal analysis, B.E.A. investigation, B.E.A. and R.A.A.; resources, K.S.V., R.A.A. and B.E.; data curation, K.S.V., B.E.A. and R.A.A.; writing—original draft preparation, B.E.A. and K.S.V.; writing—review and editing, K.S.V., B.E.A., D.A.N., J.A.L., R.A.A. and B.E.; supervision, K.S.V.; project training and administration, K.S.V., R.A.A. and B.E.; funding acquisition, K.S.V. and B.E. All authors have read, edited, and approved the published version of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Research England Global Challenge Research Fund Institutional allocation (University of Reading and University of Chester).

Institutional Review Board Statement

The GONG study was approved by the Council for Scientific and Industrial Research (CSIR) Institutional Review Board (IRB) (Ref: RPN 003/CSIR-IRB/2018). In addition, this study was approved by the Metro Director of Health Services, Kumasi (KMHD/MPHs/13). All participants signed informed consent prior to their participation.

Informed Consent Statement

The consent for publication has been obtained from all the participants.

Data Availability Statement

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Acknowledgments

We thank all the participants from the GONG study for their cooperation. Karani S. Vimaleswaran acknowledges the Public Authority for Applied Education and Training of Kuwait for the scholarship given to Buthaina AlAthari.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

SSASub-Saharan Africa
T2Dtype 2 diabetes
WCwaist circumference
BMIbody mass index
HbA1cglycated haemoglobin
VDRvitamin D receptor
DHCR77-dehydrocholesterol reductase
CYP2R125-hydroxylase
CYP24A124-hydroxylase
DBPvitamin D binding protein
GCgroup-specific component
CASRcalcium sensing receptor
GRSgenetic risk score
SNPsingle nucleotide polymorphism
HWEHardy Weinberg equilibrium
SDstandard deviation
IOMInstitute of Medicine

References

  1. Adeboye, B.; Bermano, G.; Rolland, C. Obesity and its health impact in Africa: A systematic review. Cardiovasc. J. Afr. 2012, 23, 512–521. [Google Scholar] [CrossRef] [PubMed]
  2. Ajemu, K.F.; Desta, A.A.; Berhe, A.A.; Woldegebriel, A.G.; Bezabih, N.M.; Negash, D.; Wuneh, A.D.; Woldearegay, T.W. Magnitude, components and predictors of metabolic syndrome in Northern Ethiopia: Evidences from regional NCDs STEPS survey, 2016. PLoS ONE 2021, 16, e0253317. [Google Scholar] [CrossRef] [PubMed]
  3. Mbanya, J.C.; Assah, F.K.; Saji, J.; Atanga, E.N. Obesity and Type 2 Diabetes in Sub-Sahara Africa. Curr. Diabetes Rep. 2014, 14, 1–8. [Google Scholar] [CrossRef] [PubMed]
  4. Ng, M.P.; Fleming, T.B.S.; Thomson, B.B.A.; Biryukov, S.B.S.; Abbafati, C.P.; Abraham, J.P.M.P.H.; AlBuhairan, F.S.M.; Alemu, Z.A.M.P.H.; Alfonso, R.M.D.; Ali, M.K.M.; et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014, 384, 766–781. [Google Scholar] [CrossRef] [Green Version]
  5. Scott, A.; Ejikeme, C.S.; Clottey, E.N.; Thomas, J.G. Obesity in sub-Saharan Africa: Development of an ecological theoretical framework. Health Promot. Int. 2012, 28, 4–16. [Google Scholar] [CrossRef] [Green Version]
  6. Ziraba, A.K.; Fotso, J.C.; Ochako, R. Overweight and obesity in urban Africa: A problem of the rich or the poor? BMC Public Health 2009, 9, 465. [Google Scholar] [CrossRef] [Green Version]
  7. Ofori-Asenso, R.; Agyeman, A.A.; Laar, A.; Boateng, D. Overweight and obesity epidemic in Ghana-a systematic review and meta-analysis. BMC Public Health 2016, 16, 1239. [Google Scholar] [CrossRef] [Green Version]
  8. Asamoah-Boaheng, M.; Sarfo-Kantanka, O.; Tuffour, A.B.; Eghan, B.; Mbanya, J.C. Prevalence and risk factors for diabetes mellitus among adults in Ghana: A systematic review and meta-analysis. Int. Health 2018, 11, 83–92. [Google Scholar] [CrossRef]
  9. Danquah, I.; Bedu-Addo, G.; Terpe, K.; Micah, F.; Amoako, Y.A.; Awuku, Y.A.; Dietz, E.; van der Giet, M.; Spranger, J.; Mockenhaupt, F.P. Diabetes mellitus type 2 in urban Ghana: Characteristics and associated factors. BMC Public Health 2012, 12, 210. [Google Scholar] [CrossRef] [Green Version]
  10. Tuei, V.C.; Maiyoh, G.K.; Ha, C.-E. Type 2 diabetes mellitus and obesity in sub-Saharan Africa. Diabetes/Metab. Res. Rev. 2010, 26, 433–445. [Google Scholar] [CrossRef]
  11. Polfus, L.M.; Darst, B.F.; Highland, H.; Sheng, X.; Ng MC, Y.; Below, J.E.; Petty, L.; Bien, S.; Sim, X.; Wang, W.; et al. Genetic discovery and risk characterization in type 2 diabetes across diverse populations. HGG Adv. 2021, 2. [Google Scholar] [CrossRef] [PubMed]
  12. Loos, R.J.F.; Yeo, G.S.H. The genetics of obesity: From discovery to biology. Nat. Rev. Genet. 2022, 23, 120–133. [Google Scholar] [CrossRef] [PubMed]
  13. Bahrami, A.; Sadeghnia, H.R.; Tabatabaeizadeh, S.A.; Bahrami-Taghanaki, H.; Behboodi, N.; Esmaeili, H.; Ferns, G.A.; Mobarhan, M.G.; Avan, A. Genetic and epigenetic factors influencing vitamin D status. J. Cell. Physiol. 2018, 233, 4033–4043. [Google Scholar] [CrossRef] [PubMed]
  14. Vimaleswaran, K.S.; Berry, D.J.; Lu, C.; Tikkanen, E.; Pilz, S.; Hiraki, L.T.; Cooper, J.D.; Dastani, Z.; Li, R.; Houston, D.K.; et al. Causal relationship between obesity and vitamin D status: Bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 2013, 10, e1001383. [Google Scholar] [CrossRef]
  15. Kuan, V.; Martineau, A.R.; Griffiths, C.J.; Hypponen, E.; Walton, R. DHCR7 mutations linked to higher vitamin D status allowed early human migration to northern latitudes. BMC Evol. Biol. 2013, 13, 144–153. [Google Scholar] [CrossRef] [Green Version]
  16. Berry, D.J.; Vimaleswaran, K.S.; Whittaker, J.C.; Hingorani, A.D.; Hypponen, E. Evaluation of genetic markers as instruments for Mendelian randomization studies on vitamin D. PLoS ONE 2012, 7, e37465. [Google Scholar] [CrossRef]
  17. Vimaleswaran, K.S.; Cavadino, A.; Berry, D.J.; Whittaker, J.C.; Power, C.; Jarvelin, M.R.; Hypponen, E. Genetic association analysis of vitamin D pathway with obesity traits. Int. J. Obes. 2013, 37, 1399–1406. [Google Scholar] [CrossRef] [Green Version]
  18. Abbas, M.A. Physiological functions of Vitamin D in adipose tissue. J. Steroid. Biochem. Mol. Biol. 2017, 165, 369–381. [Google Scholar] [CrossRef]
  19. Molin, A.; Coudray, N.; Richard, N.; Kottler, M.-L.; Deschenes, G.; Kesler-Roussey, G.; Tiulpakov, A.; Baudoin, R.; Jones, G.; Kaufmann, M.; et al. CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait. J. Clin. Endocrinol. Metab. 2015, 100, E1343–E1352. [Google Scholar] [CrossRef] [Green Version]
  20. Bikle, D.D.; Schwartz, J. Vitamin D Binding Protein, Total and Free Vitamin D Levels in Different Physiological and Pathophysiological Conditions. Front. Endocrinol. 2019, 10, 317. [Google Scholar] [CrossRef] [Green Version]
  21. Jiang, X.; Kiel, D.P.; Kraft, P. The genetics of vitamin D. Bone 2019, 126, 59–77. [Google Scholar] [CrossRef] [PubMed]
  22. Vimaleswaran, K.S.; Cavadino, A.; Berry, D.J.; Mangino, M.; Andrews, P.; Moore, J.H.; Spector, T.D.; Power, C.; Jarvelin, M.R.; Hypponen, E. Interaction between allelic variations in vitamin D receptor and retinoid X receptor genes on metabolic traits. BMC Genet. 2014, 15, 37. [Google Scholar]
  23. Fetahu, I.S.; Hummel, D.M.; Manhardt, T.; Aggarwal, A.; Baumgartner-Parzer, S.; Kállay, E. Regulation of the calcium-sensing receptor expression by 1,25-dihydroxyvitamin D3, interleukin-6, and tumor necrosis factor alpha in colon cancer cells. J. Steroid Biochem. Mol. Biol. 2014, 144 Pt A, 228–231. [Google Scholar] [CrossRef] [Green Version]
  24. Krasniqi, E.; Boshnjaku, A.; Wagner, K.H.; Wessner, B. Association between Polymorphisms in Vitamin D Pathway-Related Genes, Vitamin D Status, Muscle Mass and Function: A Systematic Review. Nutrients 2021, 13, 3109. [Google Scholar] [CrossRef] [PubMed]
  25. Griz, L.H.; Bandeira, F.; Gabbay, M.A.; Dib, S.A.; Carvalho, E.F. Vitamin D and diabetes mellitus: An update 2013. Arq. Bras. Endocrinol. Metabol. 2014, 58, 1–8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Mitri, J.; Muraru, M.D.; Pittas, A.G. Vitamin D and type 2 diabetes: A systematic review. Eur. J. Clin. Nutr. 2011, 65, 1005–1015. [Google Scholar]
  27. Pereira-Santos, M.; Costa, P.R.; Assis, A.M.; Santos, C.A.; Santos, D.B. Obesity and vitamin D deficiency: A systematic review and meta-analysis. Obes. Rev. 2015, 16, 341–349. [Google Scholar]
  28. Saneei, P.; Salehi-Abargouei, A.; Esmaillzadeh, A. Serum 25-hydroxy vitamin D levels in relation to body mass index: A systematic review and meta-analysis: 25(OH) vitamin D and BMI. Obes. Rev. 2013, 14, 393–404. [Google Scholar] [CrossRef]
  29. Pierce, B.L.; Ahsan, H.; VanderWeele, T.J. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int. J. Epidemiol. 2011, 40, 740–752. [Google Scholar] [CrossRef] [Green Version]
  30. Vimaleswaran, K.S. GeNuIne (gene–nutrient interactions) Collaboration: Towards implementing multi-ethnic population-based nutrigenetic studies of vitamin B12 and D deficiencies and metabolic diseases. Proc. Nutr. Soc. 2021, 80, 435–445. [Google Scholar] [CrossRef]
  31. Vimaleswaran, K.S. A nutrigenetics approach to study the impact of genetic and lifestyle factors on cardiometabolic traits in various ethnic groups: Findings from the GeNuIne Collaboration. Proc. Nutr. Soc. 2020, 79, 194–204. [Google Scholar] [CrossRef] [PubMed]
  32. Vimaleswaran, K.S. Gene–nutrient interactions on metabolic diseases: Findings from the GeNuIne Collaboration. Nutr. Bull. 2017, 42, 80–86. [Google Scholar] [CrossRef] [Green Version]
  33. Surendran, S.; Vimaleswaran, K.S. A nutrigenetic approach to examine the relationship between vitamin B12 status and cardio-metabolic traits in multiple ethnic groups—Findings from the GeNuIne Collaboration. Nutr. Bull. 2021, 46, 185–194. [Google Scholar] [CrossRef]
  34. Tuncel, G.; Temel, S.G.; Ergoren, M.C. Strong association between VDR FokI (rs2228570) gene variant and serum vitamin D levels in Turkish Cypriots. Mol. Biol. Rep. 2019, 46, 3349–3355. [Google Scholar] [CrossRef]
  35. Foucan, L.; Vélayoudom-Céphise, F.-L.; Larifla, L.; Armand, C.; Deloumeaux, J.; Fagour, C.; Plumasseau, J.; Portlis, M.-L.; Liu, L.; Bonnet, F.; et al. Polymorphisms in GC and NADSYN1 Genes are associated with vitamin D status and metabolic profile in Non-diabetic adults. BMC Endocr. Disord. 2013, 13, 36. [Google Scholar] [CrossRef] [Green Version]
  36. Wang, T.J.; Zhang, F.; Richards, J.B.; Kestenbaum, B.; van Meurs, J.B.; Berry, D.; Kiel, D.P.; Streeten, E.A.; Ohlsson, C.; Koller, D.L.; et al. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet 2010, 376, 180–188. [Google Scholar] [CrossRef] [Green Version]
  37. Xu, X.; Mao, J.; Zhang, M.; Liu, H.; Li, H.; Lei, H.; Han, L.; Gao, M. Vitamin D Deficiency in Uygurs and Kazaks Is Associated with Polymorphisms in CYP2R1 and DHCR7/NADSYN1 Genes. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2015, 21, 1960–1968. [Google Scholar]
  38. Zhang, Y.; Wang, X.; Liu, Y.; Qu, H.; Qu, S.; Wang, W.; Ren, L. The GC, CYP2R1 and DHCR7 genes are associated with vitamin D levels in northeastern Han Chinese children. Swiss Med. Wkly. 2012, 142, w13636. [Google Scholar] [CrossRef]
  39. Elkum, N.; Alkayal, F.; Noronha, F.; Ali, M.M.; Melhem, M.; Al-Arouj, M.; Bennakhi, A.; Behbehani, K.; Alsmadi, O.; Abubaker, J. Vitamin D insufficiency in Arabs and South Asians positively associates with polymorphisms in GC and CYP2R1 genes. PLoS ONE 2014, 9, e113102. [Google Scholar] [CrossRef]
  40. Kwak, S.Y.; Yongjoo Park, C.; Jo, G.; Yoen Kim, O.; Shin, M.J. Association among genetic variants in the vitamin D pathway and circulating 25-hydroxyvitamin D levels in Korean adults: Results from the Korea National Health and Nutrition Examination Survey 2011–2012. Endocr. J. 2018, 65, 881–891. [Google Scholar] [CrossRef] [Green Version]
  41. Hibler, E.A.; Hu, C.; Jurutka, P.W.; Martinez, M.E.; Jacobs, E.T. Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia. Cancer Epidemiol. Biomark. Prev. 2012, 21, 368–375. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Batai, K.; Murphy, A.B.; Shah, E.; Ruden, M.; Newsome, J.; Agate, S.; Dixon, M.A.; Chen, H.Y.; Deane, L.A.; Hollowell, C.M.P.; et al. Common vitamin D pathway gene variants reveal contrasting effects on serum vitamin D levels in African Americans and European Americans. Hum. Genet. 2014, 133, 1395–1405. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Bu, F.-X.; Armas, L.; Lappe, J.; Zhou, Y.; Gao, G.; Wang, H.-W.; Recker, R.; Zhao, L.-J. Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects. Hum. Genet. 2010, 128, 549–556. [Google Scholar] [CrossRef]
  44. Clendenen, T.V.; Ge, W.; Koenig, K.L.; Axelsson, T.; Liu, M.; Afanasyeva, Y.; Andersson, A.; Arslan, A.A.; Chen, Y.; Hallmans, G.; et al. Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study. PLoS ONE 2015, 10, e0140478. [Google Scholar] [CrossRef]
  45. Cooper, J.D.; Smyth, D.J.; Walker, N.M.; Stevens, H.; Burren, O.S.; Wallace, C.; Greissl, C.; Ramos-Lopez, E.; Hyppönen, E.; Dunger, D.B.; et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011, 60, 1624–1631. [Google Scholar] [CrossRef] [Green Version]
  46. Davies, J.R.; Chang, Y.M.; Snowden, H.; Chan, M.; Leake, S.; Karpavicius, B.; Haynes, S.; Kukalizch, K.; Randerson-Moor, J.; Elliott, F.; et al. The determinants of serum vitamin D levels in participants in a melanoma case-control study living in a temperate climate. Cancer Causes Control 2011, 22, 1471–1482. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Gilbert, R.; Bonilla, C.; Metcalfe, C.; Lewis, S.; Evans, D.M.; Fraser, W.D.; Kemp, J.P.; Donovan, J.L.; Hamdy, F.C.; Neal, D.E.; et al. Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: A nested case-control study. Cancer Causes Control 2015, 26, 205–218. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Nissen, J.; Rasmussen, L.B.; Ravn-Haren, G.; Andersen, E.W.; Hansen, B.; Andersen, R.; Mejborn, H.; Madsen, K.H.; Vogel, U. Common variants in CYP2R1 and GC genes predict vitamin D concentrations in healthy Danish children and adults. PLoS ONE 2014, 9, e89907. [Google Scholar] [CrossRef] [Green Version]
  49. Nissen, J.; Vogel, U.; Ravn-Haren, G.; Andersen, E.W.; Madsen, K.H.; Nexø, B.A.; Andersen, R.; Mejborn, H.; Bjerrum, P.J.; Rasmussen, L.B.; et al. Common variants in CYP2R1 and GC genes are both determinants of serum 25-hydroxyvitamin D concentrations after UVB irradiation and after consumption of vitamin D3–fortified bread and milk during winter in Denmark. Am. J. Clin. Nutr. 2015, 101, 218–227. [Google Scholar] [CrossRef] [Green Version]
  50. Ordóñez-Mena, J.M.; Maalmi, H.; Schöttker, B.; Saum, K.-U.; Holleczek, B.; Wang, T.J.; Burwinkel, B.; Brenner, H. Genetic Variants in the Vitamin D Pathway, 25(OH)D Levels, and Mortality in a Large Population-Based Cohort Study. J. Clin. Endocrinol. Metab. 2017, 102, 470–477. [Google Scholar] [CrossRef] [Green Version]
  51. Rees, J.R.; Mott, L.A.; Barry, E.L.; Baron, J.A.; Bostick, R.M.; Figueiredo, J.C.; Bresalier, R.S.; Robertson, D.J.; Peacock, J.L. Lifestyle and Other Factors Explain One-Half of the Variability in the Serum 25-Hydroxyvitamin D Response to Cholecalciferol Supplementation in Healthy Adults. J. Nutr. 2016, 146, 2312–2324. [Google Scholar] [PubMed] [Green Version]
  52. Slater, N.A.; Rager, M.L.; Havrda, D.E.; Harralson, A.F. Genetic Variation in CYP2R1 and GC Genes Associated with Vitamin D Deficiency Status. J. Pharm. Pract. 2015, 30, 31–36. [Google Scholar] [CrossRef] [PubMed]
  53. Janssens, A.C.; Moonesinghe, R.; Yang, Q.; Steyerberg, E.W.; van Duijn, C.M.; Khoury, M.J. The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet. Med. 2007, 9, 528–535. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Moselakgomo, V.K.; Van Staden, M. Diagnostic accuracy of tri-ponderal mass index and body mass index in estimating overweight and obesity in South African children. Afr. J. Prim. Health Care Fam. Med. 2019, 11, e1–e7. [Google Scholar] [CrossRef]
  55. Zafra-Tanaka, J.H.; Miranda, J.J.; Gilman, R.H.; Checkley, W.; Smeeth, L.; Bernabe-Ortiz, A. Obesity markers for the prediction of incident type 2 diabetes mellitus in resource-poor settings: The CRONICAS Cohort Study. Diabetes Res. Clin. Pract. 2020, 170, 108494. [Google Scholar] [CrossRef]
  56. Alaboudi, I.S.; Hassali, M.A.; Shafie, A.A.; Saleem, F. Self-efficacy, self-care behaviours and glycaemic control in type 2 diabetic patients in Riyadh, Saudi Arabia. J. Public Health 2016, 24, 281–290. [Google Scholar] [CrossRef]
  57. Woo, V.; Shestakova, M.V.; Ørskov, C.; Ceriello, A. Targets and tactics: The relative importance of HbA1c, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes. Int. J. Clin. Pract. 2008, 62, 1935–1942. [Google Scholar] [CrossRef]
  58. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids; The National Academies Press: Washington, DC, USA, 2005; p. 1358. [Google Scholar]
  59. Howarth, N.C.; Saltzman, E.; Roberts, S.B. Dietary Fiber and Weight Regulation. Nutr. Rev. 2001, 59, 129–139. [Google Scholar] [CrossRef]
  60. Murakami, K.; Sasaki, S.; Okubo, H.; Takahashi, Y.; Hosoi, Y.; Itabashi, M.; the Freshmen in Dietetic Courses Study II Group. Dietary fiber intake, dietary glycemic index and load, and body mass index: A cross-sectional study of 3931 Japanese women aged 18–20 years. Eur. J. Clin. Nutr. 2007, 61, 986–995. [Google Scholar] [CrossRef] [Green Version]
  61. Ley, S.H.; Hamdy, O.; Mohan, V.; Hu, F.B. Prevention and management of type 2 diabetes: Dietary components and nutritional strategies. Lancet 2014, 383, 1999–2007. [Google Scholar] [CrossRef] [Green Version]
  62. Neuenschwander, M.; Barbaresko, J.; Pischke, C.R.; Iser, N.; Beckhaus, J.; Schwingshackl, L.; Schlesinger, S. Intake of dietary fats and fatty acids and the incidence of type 2 diabetes: A systematic review and dose-response meta-analysis of prospective observational studies. PLoS Med. 2020, 17, e1003347. [Google Scholar] [CrossRef] [PubMed]
  63. Doglikuu, B.-I.D.; Abubakari, A.; Yaseri, M.; Shakibazadeh, E.; Djazayery, A.; Mirzaei, K. Association of household socioeconomic status, neighborhood support system and adherence to dietary recommendation among persons with T2DM, a facility-based cross-sectional study in Ghana. BMC Public Health 2021, 21, 911. [Google Scholar] [CrossRef] [PubMed]
  64. Beane, K.E.; Redding, M.C.; Wang, X.; Pan, J.H.; Le, B.; Cicalo, C.; Jeon, S.; Kim, Y.J.; Lee, J.H.; Shin, E.-C.; et al. Effects of dietary fibers, micronutrients, and phytonutrients on gut microbiome: A review. Appl. Biol. Chem. 2021, 64, 36. [Google Scholar] [CrossRef]
  65. Roager, H.M.; Christensen, L.H. Personal diet–microbiota interactions and weight loss. Proc. Nutr. Soc. 2022, 1–12. [Google Scholar] [CrossRef]
  66. Cronin, P.; Joyce, S.A.; O’Toole, P.W.; O’Connor, E.M. Dietary fibre modulates the gut microbiota. Nutrients 2021, 13, 1655. [Google Scholar] [CrossRef]
  67. Liu, Z.; Li, L.; Ma, S.; Ye, J.; Zhang, H.; Li, Y.; Sair, A.T.; Pan, J.; Liu, X.; Li, X. High-dietary fiber intake alleviates antenatal obesity-induced postpartum depression: Roles of gut microbiota and microbial metabolite short-chain fatty acid involved. J. Agric. Food Chem. 2020, 68, 13697–13710. [Google Scholar] [CrossRef]
  68. Aoun, A.; Darwish, F.; Hamod, N. The influence of the gut microbiome on obesity in adults and the role of probiotics, prebiotics, and synbiotics for weight loss. Prev. Nutr. Food Sci. 2020, 25, 113. [Google Scholar] [CrossRef]
  69. Ellulu, M.S.; Patimah, I.; Khaza’ai, H.; Rahmat, A.; Abed, Y. Obesity and inflammation: The linking mechanism and the complications. Arch. Med. Sci. AMS 2017, 13, 851–863. [Google Scholar] [CrossRef]
  70. Ly, N.P.; Litonjua, A.; Gold, D.R.; Celedón, J.C. Gut microbiota, probiotics, and vitamin D: Interrelated exposures influencing allergy, asthma, and obesity? J. Allergy Clin. Immunol. 2011, 127, 1087–1096. [Google Scholar] [CrossRef]
  71. Sun, J. Dietary vitamin D, vitamin D receptor, and microbiome. Curr. Opin. Clin. Nutr. Metab. Care 2018, 21, 471–474. [Google Scholar] [CrossRef]
  72. Wang, J.; Thingholm, L.B.; Skiecevičienė, J.; Rausch, P.; Kummen, M.; Hov, J.R.; Degenhardt, F.; Heinsen, F.-A.; Rühlemann, M.C.; Szymczak, S.; et al. Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. Nat. Genet. 2016, 48, 1396–1406. [Google Scholar] [CrossRef] [PubMed]
  73. Vimaleswaran, K.S.; Bodhini, D.; Lakshmipriya, N.; Ramya, K.; Anjana, R.M.; Sudha, V.; Lovegrove, J.A.; Kinra, S.; Mohan, V.; Radha, V. Interaction between FTO gene variants and lifestyle factors on metabolic traits in an Asian Indian population. Nutr. Metab. 2016, 13, 39. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Alsulami, S.; Nyakotey, D.A.; Dudek, K.; Bawah, A.-M.; Lovegrove, J.A.; Annan, R.A.; Ellahi, B.; Vimaleswaran, K.S. Interaction between Metabolic Genetic Risk Score and Dietary Fatty Acid Intake on Central Obesity in a Ghanaian Population. Nutrients 2020, 12, 1906. [Google Scholar] [CrossRef] [PubMed]
  75. Lie, L.; Brown, L.; Forrester, T.E.; Plange-Rhule, J.; Bovet, P.; Lambert, E.V.; Layden, B.T.; Luke, A.; Dugas, L.R. The Association of Dietary Fiber Intake with Cardiometabolic Risk in Four Countries across the Epidemiologic Transition. Nutrients 2018, 10, 628. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Steyn, N.P.; Mchiza, Z.J. Obesity and the nutrition transition in Sub-Saharan Africa. Ann. N. Y. Acad. Sci. 2014, 1311, 88–101. [Google Scholar] [CrossRef]
  77. Mehta, S.; Ruth Dugas, L.; Choo-Kang, C.; Bovet, P.; Forrester, T.; Bedu-Addo, K.; Lambert, E.V.; Plange-Rhule, J.; Riesen, W.; Korte, W.; et al. Consumption of Monounsaturated Fatty Acids Is Associated with Improved Cardiometabolic Outcomes in Four African-Origin Populations Spanning the Epidemiologic Transition. Nutrients 2021, 13, 2442. [Google Scholar] [CrossRef]
  78. Suara, S.B.; Siassi, F.; Saaka, M.; Rahimiforoushani, A.; Sotoudeh, G. Relationship between dietary carbohydrate quality index and metabolic syndrome among type 2 diabetes mellitus subjects: A case-control study from Ghana. BMC Public Health 2021, 21, 526. [Google Scholar] [CrossRef]
  79. Buscemi, J.; Pugach, O.; Springfield, S.; Jang, J.; Tussing-Humphreys, L.; Schiffer, L.; Stolley, M.R.; Fitzgibbon, M.L. Associations between fiber intake and Body Mass Index (BMI) among African-American women participating in a randomized weight loss and maintenance trial. Eat. Behav. 2018, 29, 48–53. [Google Scholar] [CrossRef]
  80. Holdsworth, M.; Pradeilles, R.; Tandoh, A.; Green, M.; Wanjohi, M.; Zotor, F.; Asiki, G.; Klomegah, S.; Abdul-Haq, Z.; Osei-Kwasi, H.; et al. Unhealthy eating practices of city-dwelling Africans in deprived neighbourhoods: Evidence for policy action from Ghana and Kenya. Glob. Food Secur. 2020, 26, 100452. [Google Scholar] [CrossRef]
  81. Saleh, A.; Amanatidis, S.; Samman, S. The effect of migration on dietary intake, type 2 diabetes and obesity: The Ghanaian Health and Nutrition Analysis in Sydney, Australia (GHANAISA). Ecol. Food Nutr. 2002, 41, 255–270. [Google Scholar] [CrossRef]
  82. Wolpert, H.A.; Atakov-Castillo, A.; Smith, S.A.; Steil, G.M. Dietary fat acutely increases glucose concentrations and insulin requirements in patients with type 1 diabetes: Implications for carbohydrate-based bolus dose calculation and intensive diabetes management. Diabetes Care 2013, 36, 810–816. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Grylls, W.K.; McKenzie, J.E.; Horwath, C.C.; Mann, J.I. Lifestyle factors associated with glycaemic control and body mass index in older adults with diabetes. Eur. J. Clin. Nutr. 2003, 57, 1386–1393. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Smart, C.E.M.; Evans, M.; O’Connell, S.M.; McElduff, P.; Lopez, P.E.; Jones, T.W.; Davis, E.A.; King, B.R. Both dietary protein and fat increase postprandial glucose excursions in children with type 1 diabetes, and the effect is additive. Diabetes Care 2013, 36, 3897–3902. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Garonzi, C.; Forsander, G.; Maffeis, C. Impact of Fat Intake on Blood Glucose Control and Cardiovascular Risk Factors in Children and Adolescents with Type 1 Diabetes. Nutrients 2021, 13, 2625. [Google Scholar] [CrossRef] [PubMed]
  86. Li, S.; Zhao, J.H.; Luan, J.; Luben, R.N.; Rodwell, S.A.; Khaw, K.T.; Ong, K.K.; Wareham, N.J.; Loos, R.J. Cumulative effects and predictive value of common obesity-susceptibility variants identified by genome-wide association studies. Am. J. Clin. Nutr. 2010, 91, 184–190. [Google Scholar] [CrossRef] [Green Version]
  87. Babb de Villiers, C.; Kroese, M.; Moorthie, S. Understanding polygenic models, their development and the potential application of polygenic scores in healthcare. J. Med. Genet. 2020, 57, 725–732. [Google Scholar] [CrossRef]
  88. Lewis, C.M.; Vassos, E. Polygenic risk scores: From research tools to clinical instruments. Genome Med. 2020, 12, 44. [Google Scholar] [CrossRef]
  89. National Centre for Biotechnology Information. Available online: https://www.ncbi.nlm.nih.gov/snp/ (accessed on 26 June 2022).
Nutrients 14 02763 g001 550
Figure 1. Flow chart showing the recruitment of the study participants.
Figure 1. Flow chart showing the recruitment of the study participants.
Nutrients 14 02763 g001
Nutrients 14 02763 g002 550
Figure 2. (A) Interaction between vitamin D-GRS and total dietary fiber intake (g) on log BMI (pinteraction = 0.020); Participants who consumed lower fiber (≤16.19 g/d) and carried ≥2 risk alleles (mean ± SE: 1.45 ± 0.009) had significantly higher BMI than participants with <2 vitamin D risk alleles (mean ± SE: 1.40 ± 0.015). (B) Interaction between vitamin D-GRS and total fat intake (g) on log HbA1c (pinteraction = 0.020); Participants who consumed lower fat intake (≤36.47 g/d) and carried ≥2 risk alleles (mean ± SE: 0.72 ± 0.005) had significantly lower HbA1c than participants with <2 risk alleles (mean ± SE: 0.74 ± 0.010).
Figure 2. (A) Interaction between vitamin D-GRS and total dietary fiber intake (g) on log BMI (pinteraction = 0.020); Participants who consumed lower fiber (≤16.19 g/d) and carried ≥2 risk alleles (mean ± SE: 1.45 ± 0.009) had significantly higher BMI than participants with <2 vitamin D risk alleles (mean ± SE: 1.40 ± 0.015). (B) Interaction between vitamin D-GRS and total fat intake (g) on log HbA1c (pinteraction = 0.020); Participants who consumed lower fat intake (≤36.47 g/d) and carried ≥2 risk alleles (mean ± SE: 0.72 ± 0.005) had significantly lower HbA1c than participants with <2 risk alleles (mean ± SE: 0.74 ± 0.010).
Nutrients 14 02763 g002
Table
Table 1. Baseline characteristics of study participants.
Table 1. Baseline characteristics of study participants.
nTotalnMennWomenp Value
Age (years)27938 ± 1011536 ± 916440 ± 100.003
BMI (kg/m2)27926.6 ± 4.9111523.6 ± 3.0216428.7 ± 4.92<0.001
WC (cm)27988.4 ± 12.2211581.8 ± 9.9216493 ± 11.59<0.001
WHR2791.5 ± 7.241150.9 ± 0.11641.9 ± 9.430.15
BFP (%)27932.9 ± 13.5511520.5 ± 10.0116441.6 ± 7.58<0.001
Glucose (mg/dl)2784.4 ± 0.911154.3 ± 0.591634.4 ± 1.090.33
HbA1c (%)2755.3 ± 0.581115.3 ± 0.51645.3 ± 0.620.94
Fasting Insulin (µIU/mL)27012.6 ± 14.3810913.1 ± 16.0816112.3 ± 13.150.62
Total Cholesterol (mg/dL)276212.7 ± 58113208.8 ± 41.76163216.6 ± 39.060.07
HDL-c (mg/dL)27669.6 ± 7.7011369.6 ± 7.3516365.7 ± 0.7.730.12
LDL-c (mg/dL)276127.6 ± 41.76113123.7 ± 42.54163131.5 ± 40.990.06
Serum Triglycerides (mg/dL)27687.3 ± 32.7811386.8 ± 29.2316387.7 ± 36.320.98
Total Energy Intake (kcal)2791645 ± 6881151901 ± 7141641465 ± 610<0.001
Protein (g)27953 ± 2311563 ± 2416446 ± 19<0.001
Carbohydrate (g)279240 ± 98115281 ± 104164211 ± 81<0.001
Fat (g)27951 ± 2711557 ± 2916447 ± 240.001
Saturated fat (g)27916 ± 1011518 ± 1116415 ± 90.006
Monounsaturated fat (g)27918 ± 1011520 ± 1116416 ± 90.002
Polyunsaturated fat (g)2799 ± 511510 ± 61648 ± 50.002
Dietary Fibre (g)27922 ± 1111525 ± 1216419 ± 10<0.001
Data are presented as means ± SD, p values for the differences in the means between the two groups were calculated by using the independent samples t-test, Abbreviations: BMI: body mass index, WC: waist circumference, WHR: waist–hip ratio; BFP: body fat percentage; HbA1c: glycated hemoglobin; HDL-c: high-density lipoprotein cholesterol; LDL-c: low-density lipoprotein cholesterol.
Table
Table 2. Interaction between dietary factors and vitamin D-GRS on clinical and metabolic traits.
Table 2. Interaction between dietary factors and vitamin D-GRS on clinical and metabolic traits.
Carbohydrates (g)Protein (g)Fat (g)Fibre (g)SFA (g)PUFA (g)MUFA (g)
BMI (kg/m2)0.050.160.990.02
WC (cm)0.160.070.220.13
WHR0.720.760.850.87
BFP (%)1.000.270.220.12
Glucose (mg/dL)0.980.830.880.52
HbA1c (ng/mL)0.060.120.030.100.040.130.84
Fasting Insulin (µIU/mL)0.350.680.430.13
GLM was used to perform interaction analysis. All variables were log transformed. All associations were adjusted for age, gender, BMI (except BMI which was not adjusted for when the outcome was BMI) and total energy. The analysis was conducted on log-transformed variables. Abbreviations: GRS: genetic risk score, BMI: body mass index, WC: waist circumference, WHR: waist–hip ratio, BFP: body fat percentage, HbA1c: glycated hemoglobin.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Alathari, B.E.; Nyakotey, D.A.; Bawah, A.-M.; Lovegrove, J.A.; Annan, R.A.; Ellahi, B.; Vimaleswaran, K.S. Interactions between Vitamin D Genetic Risk and Dietary Factors on Metabolic Disease-Related Outcomes in Ghanaian Adults. Nutrients 2022, 14, 2763. https://doi.org/10.3390/nu14132763

AMA Style

Alathari BE, Nyakotey DA, Bawah A-M, Lovegrove JA, Annan RA, Ellahi B, Vimaleswaran KS. Interactions between Vitamin D Genetic Risk and Dietary Factors on Metabolic Disease-Related Outcomes in Ghanaian Adults. Nutrients. 2022; 14(13):2763. https://doi.org/10.3390/nu14132763

Chicago/Turabian Style

Alathari, Buthaina E., David A. Nyakotey, Abdul-Malik Bawah, Julie A. Lovegrove, Reginald A. Annan, Basma Ellahi, and Karani S. Vimaleswaran. 2022. "Interactions between Vitamin D Genetic Risk and Dietary Factors on Metabolic Disease-Related Outcomes in Ghanaian Adults" Nutrients 14, no. 13: 2763. https://doi.org/10.3390/nu14132763

APA Style

Alathari, B. E., Nyakotey, D. A., Bawah, A. -M., Lovegrove, J. A., Annan, R. A., Ellahi, B., & Vimaleswaran, K. S. (2022). Interactions between Vitamin D Genetic Risk and Dietary Factors on Metabolic Disease-Related Outcomes in Ghanaian Adults. Nutrients, 14(13), 2763. https://doi.org/10.3390/nu14132763

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop